Primis Financial Corp. (FRST)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 headline loss driven by consumer program winddown: net loss to common of $14.7M and diluted EPS of $(0.59), as the company moved $133M of third‑party consumer loans to held for sale and took $20.0M of marks and charge-offs . Underlying net interest margin would have been 3.18% excluding $2.5M of interest reversals; deposit cost fell 24 bps sequentially to 2.80%, with a further ~65 bps reduction on ~$1B of digital deposits repriced in Dec/Jan (≈$6.5M annual savings) .
- Strategic repositioning: sale of Life Premium Finance (LPF) generated a $4.723M gain; mortgage warehouse launched (SOFR+340 bps yield), with 54 approved customers and >$400M of committed lines by end‑Jan 2025; 2025 mortgage production targeted at ~$1.25B .
- Panacea Financial momentum: loans up to ~$434M (+11% q/q) and deposits ~$92M; management exploring deconsolidation to recognize economic value, believed above the ~$19.6M mark at 12/31/23 .
- Capital return and listing: $0.10 dividend declared (53rd consecutive) and stock repurchase reauthorization (up to 740,600 shares); Nasdaq compliance regained with a one‑year panel monitor .
What Went Well and What Went Wrong
What Went Well
- Deposit cost inflection and margin trajectory: “Cost of deposits decreased 24 basis points to 2.80%… [digital] deposit costs have declined by approximately 65 basis points… implying additional savings of approximately $6.5 million annually” . Ex‑reversal NIM would have been 3.18% vs 2.86% in Q4’23 .
- Mortgage warehouse build and pricing: 54 approved customers, >$400M committed lines; average yield SOFR + 340 bps (Dec) . CEO: “We are positioned to push margins in the 3.25% to 3.50% range on this national strategy” .
- Panacea expansion and value optionality: loans ~$434M and deposits ~$92M; management believes deconsolidation can unlock value above prior ~$19.6M mark; “we can probably move to… just deconsolidate it” .
What Went Wrong
- Elevated credit costs from consumer program exit: Q4 provision $23.0M (vs $7.5M in Q3); consumer program drove $20.8M of provision and $30.5M of net charge‑offs, pushing NCO ratio to 3.84% (core NCO 0.05%) .
- Noninterest expense spike: Q4 noninterest expense rose to $37.2M (from $31.0M in Q3), with core operating burden up $3.7M q/q to $23.5M, partly due to comp accruals, FDIC, consulting and tech implementation fees .
- Net interest income compressed by transition: Q4 NII fell $1.9M q/q to $26.1M, impacted by $2.5M interest reversals on consumer charge‑offs and ~$1.3M decline tied to LPF sale; mortgage banking income fell $1.8M q/q on seasonal factors .
Financial Results
Note: The Q3 2024 net income to common differs slightly between Q3 release ($1.212M) and Q4 tables updating prior quarters ($1.228M); table uses updated Q4 filing values .
Segment/Line-of-Business Indicators
Key Performance Indicators
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO (Dennis Zember): “We are positioned to push margins in the 3.25% to 3.50% range on this national strategy with efficient platforms and safe short-term asset strategies” .
- CEO: “Our moves in the fourth quarter neutralized $20 million of credit costs… that number moves to about $17 million annually once warehouse is at scale in ’25” .
- CFO (Matt Switzer): “Without [consumer program] items, we would have made $7.1 million pretax… after the net impact of these items, the bank would have made approximately $6.2 million pretax in the fourth quarter” .
- CFO on deposit rates: delays in digital platform repricing cost “another $1 million approximately of interest carry in the fourth quarter” .
- CEO on Panacea deconsolidation: “I can just confidently say that it’s not less than what we did last time… I think we can probably move to… just deconsolidate it” .
Q&A Highlights
- Loan growth outlook: Core bank pipeline doubled y/y; 2025 bank loan growth targeted
$125–$175M; mortgage warehouse modeled to replace LPF ($300M) with larger long‑term potential . - NIM cadence: Management expects margin expansion through 2025, exiting near upper end of 3.25–3.50%, aided by lower deposit costs, warehouse/construction‑perm yields, and asset repricing .
- Credit/Provision baseline: Core charge‑offs ~5–10 bps; warehouse reserve burden modeled ~15 bps; provision ~$1M per quarter near‑term .
- Panacea value recognition: Deconsolidation (not monetization) under consideration to reflect higher valuation; operational steps required (employee/services transfer) .
- Deposit mix strategy: Aim to grow core bank deposits to ~$2.5B in two years, with digital side remixing to more lower‑cost checking within existing ~$1B base .
Estimates Context
Consensus EPS and revenue estimates from S&P Global for FRST were not available at time of analysis due to an API rate limit error. As a result, we cannot quantify beat/miss versus Street for Q4 2024 and Q3 2024 at this time. Attempted retrieval from S&P Global but rate limit prevented access.
Note: Consensus estimates unavailable via S&P Global due to rate limits; will update when accessible.
Key Takeaways for Investors
- Q4 print was intentionally “kitchen‑sink” to exit the consumer program; underlying profitability trajectory improves in 2025 as mix shifts to warehouse/construction‑perm and deposit costs continue to fall .
- Margin expansion catalysts are tangible: digital repricing (~65 bps on ~$1B deposits), asset repricing ($350M loans at ~5.90% in 2025), and warehouse yields (SOFR+340 bps) .
- Credit normalization outside the consumer book looks benign (core NCO ~0.05%), supporting lower provision run‑rate as warehouse scales .
- Panacea remains a strategic asset with accelerating deposits and loan growth; deconsolidation could lift tangible book/value visibility without reducing FRST’s ~19% ownership .
- Near‑term OpEx elevated by one‑time items; core operating expense burden guided to $21–$22M per quarter in 2025, providing operating leverage as revenue drivers scale .
- Capital return intact and listing risks addressed: dividend maintained; repurchase program reauthorized; Nasdaq compliance regained with panel monitor .
- Trading angle: watch for 1H25 updates on Panacea deconsolidation, warehouse balance ramp, NIM progression, and further deposit mix improvements—key catalysts for multiple re‑rating and TBV accretion .
Citations: Q4 2024 8‑K and exhibits ; Q4 earnings call transcripts ; Q4 press release ; Q3 press release ; Q2 preliminary press release ; Stock buyback/Nasdaq press .